Pretorius E, Wallner B, Marx J
Department of Anatomy, School of Health Sciences, Medical Faculty of the University of Pretoria, South Africa.
Horm Metab Res. 2006 Jun;38(6):368-76. doi: 10.1055/s-2006-944530.
The two types of corticosteroid hormones, the mineralocorticoids and glucocorticoids, act in a complementary manner and are functionally closely linked. Aldosterone and glucocorticoids express their functions through the glucocorticoid receptors (GRs; GRalpha and GRbeta) and the mineralocorticoid receptors (MRs). Commercially available steroidal drugs used in conditions such as asthma may act on both GR and MR receptors; although glucocorticoid-receptor agonists play a fundamental role in the treatment of inflammatory conditions, prolonged exposure may have adverse effects such as the development of resistance. Glucocorticoid resistance in such conditions has been observed to be accompanied by a downregulation of GRalpha, a twofold decrease in GR protein half-life, downregulation of GRalpha mRNA expression, and enhanced expression of GRbeta. Other suggestions for glucocorticoid resistance include alternative splicing of the GR gene with subsequent expression of the GRbeta protein isoform, defective regulation of gene transcription of the GR gene or GR mutations, defective DNA binding and transactivating domains of the GR. In addition, we would like to suggest that dysregulation of the MR enzyme 11beta-HSD-2 may be one of the causes of resistance. When expressed in cells with MRs, this enzyme's major role is to prevent permanent occupancy of MR by glucocorticoid hormones, allowing concentration-dependent binding of aldosterone to MR. However, deficiency of the 11beta-HSD isoforms (particularly 11beta-HSD-2) leads to the activation of MRs by glucocorticoids rather than the glucocorticoids interacting with its "normal" receptors, the GRs. We will substantiate on support for our hypothesis in the dysregulation of this enzyme, which is typically associated with significantly higher levels of circulating plasma cortisol and elevated levels of cholesterol, little or no response to systemic glucocorticoids, and problems associated with homeostasis primarily in the distal nephron and distal colon. These are some of the symptoms typically noted in cortisol resistance.
盐皮质激素和糖皮质激素这两种皮质类固醇激素以互补方式发挥作用,在功能上紧密相连。醛固酮和糖皮质激素通过糖皮质激素受体(GRs;GRα和GRβ)以及盐皮质激素受体(MRs)发挥其功能。用于治疗哮喘等病症的市售甾体药物可能作用于GR和MR受体;虽然糖皮质激素受体激动剂在炎症性疾病的治疗中发挥着重要作用,但长期接触可能会产生不良影响,如产生耐药性。在这些情况下,已观察到糖皮质激素抵抗伴随着GRα的下调、GR蛋白半衰期降低两倍、GRα mRNA表达下调以及GRβ表达增强。关于糖皮质激素抵抗的其他推测包括GR基因的可变剪接以及随后GRβ蛋白异构体的表达、GR基因转录调控缺陷或GR突变、GR的DNA结合和反式激活结构域缺陷。此外,我们认为MR酶11β - HSD - 2的失调可能是耐药性的原因之一。当在表达MRs的细胞中表达时,这种酶的主要作用是防止糖皮质激素永久性占据MR,从而使醛固酮能够以浓度依赖的方式与MR结合。然而,11β - HSD异构体(特别是11β - HSD - 2)的缺乏会导致糖皮质激素激活MRs,而不是糖皮质激素与其“正常”受体GRs相互作用。我们将在该酶失调方面为我们的假设提供证据支持,这种失调通常与循环血浆皮质醇水平显著升高、胆固醇水平升高、对全身性糖皮质激素几乎无反应以及主要在远端肾单位和远端结肠的内环境稳态问题相关。这些是皮质醇抵抗中通常会出现的一些症状。